FDA Loosens Reins on 23andMe Gene Tests
After selling out to Big Pharma, 23andMe went from being a pariah with the FDA to being a darling. Recently, the FDA approved 23andMe’s direct-to-consumer genetic tests for ten conditions, including Parkinson’s disease, Alzheimer’s, and celiac disease. Consumers send 23andMe a saliva sample, and the company sends back genetic data analyzing the disease risk of […]